Related Experiment Video
Updated: Jul 6, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Uncovering hidden cancer self-dependencies through analysis of shRNA-level dependency scores
Zohreh Toghrayee1,2, Hesam Montazeri3
1Department of Bioinformatics, Institute Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Abstract:
Large-scale short hairpin RNA (shRNA) screens on well-characterized human cancer cell lines have been widely used to identify novel cancer dependencies. However, the off-target effects of shRNA reagents pose a significant challenge in the analysis of these screens. To mitigate these off-target effects, various approaches have been proposed that aggregate different shRNA viability scores targeting a gene into a single gene-level viability score. Most computational methods for discovering cancer dependencies rely on these gene-level scores. In this paper, we propose a computational method, named NBDep, to find cancer self-dependencies by directly analyzing shRNA-level dependency scores instead of gene-level scores. The NBDep algorithm begins by removing known batch effects of the shRNAs and selecting a subset of concordant shRNAs for each gene. It then uses negative binomial random effects models to statistically assess the dependency between genetic alterations and the viabilities of cell lines by incorporating all shRNA dependency scores of each gene into the model. We applied NBDep to the shRNA dependency scores available at Project DRIVE, which covers 26 different types of cancer. The proposed method identified more well-known and putative cancer genes compared to alternative gene-level approaches in pan-cancer and cancer-specific analyses. Additionally, we demonstrated that NBDep controls type-I error and outperforms statistical tests based on gene-level scores in simulation studies.
Insights
This study introduces NBDep, a new computational method for identifying cancer dependencies by directly analyzing short hairpin RNA (shRNA) data. NBDep improves upon existing methods by mitigating off-target effects, leading to more accurate identification of cancer-driving genes.
Area of Science:
- Computational biology
- Cancer genomics
- Functional genomics
Background:
- Large-scale short hairpin RNA (shRNA) screens are crucial for identifying cancer dependencies in human cancer cell lines.
- Off-target effects of shRNA reagents present a significant challenge in analyzing screen data.
- Current computational methods often rely on aggregated gene-level scores, potentially masking true dependencies.
Purpose of the Study:
- To develop a novel computational method, NBDep, for identifying cancer dependencies.
- To directly analyze shRNA-level dependency scores, bypassing the limitations of gene-level aggregation.
- To improve the accuracy and robustness of cancer dependency discovery in large-scale screens.
Main Methods:
- Developed the NBDep algorithm to analyze shRNA-level dependency scores directly.
- Implemented batch effect removal and selection of concordant shRNAs for each gene.
- Utilized negative binomial random effects models to assess gene-viability associations across cell lines.
Main Results:
- NBDep identified more known and putative cancer genes than alternative gene-level approaches in pan-cancer and cancer-specific analyses.
- The method was applied to shRNA dependency scores from Project DRIVE, covering 26 cancer types.
- Simulation studies demonstrated that NBDep effectively controls type-I error and outperforms gene-level score-based tests.
Conclusions:
- NBDep offers a more accurate and robust approach to discovering cancer dependencies from shRNA screen data.
- Directly analyzing shRNA-level scores mitigates off-target effects, enhancing the reliability of identified cancer dependencies.
- The NBDep method shows promise for advancing cancer research and therapeutic target identification.
More Related Videos
04:58Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance
Published on: December 13, 2024
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Nucleolus
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...